{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:40:52Z","timestamp":1790876452615,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jiac.2019.04.017","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T11:05:51Z","timestamp":1558436751000},"page":"735-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation for optimal dosing of vancomycin in patients with different physical types"],"prefix":"10.1016","volume":"25","author":[{"given":"Mari","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Iketani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5934-0670","authenticated-orcid":false,"given":"Yuki","family":"Enoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-6138","authenticated-orcid":false,"given":"Shunsuke","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Uwamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-7450","authenticated-orcid":false,"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.04.017_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/491708","article-title":"Vancomycin: a 50-year reassessment","volume":"42","author":"Moellering","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jiac.2019.04.017_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.04.017_bib3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.04.017_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10156-013-0599-4","article-title":"Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"19","author":"Matsumoto","year":"2013","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.04.017_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dkl030","article-title":"Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia","volume":"57","author":"Sakoulas","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2019.04.017_bib6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.clinthera.2007.06.014","article-title":"A\u00a0retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia","volume":"29","author":"Jeffres","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiac.2019.04.017_bib7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1345\/aph.1P634","article-title":"Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software","volume":"45","author":"Nunn","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jiac.2019.04.017_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00007691-199410000-00013","article-title":"Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight","volume":"16","author":"Ducharme","year":"1994","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jiac.2019.04.017_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/phar.1588","article-title":"Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment","volume":"35","author":"Hong","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2019.04.017_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jiac.2015.03.007","article-title":"The association of elevated trough serum vancomycin concentrations with obesity","volume":"21","author":"Richardson","year":"2015","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.04.017_bib11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/phar.1625","article-title":"Vancomycin dosing considerations in a real-world cohort of obese and extremely obese patients","volume":"35","author":"Morrill","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2019.04.017_bib12","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/phar.2023","article-title":"Comprehensive guidance for antibiotic dosing in obese adults","volume":"37","author":"Meng","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2019.04.017_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.jiac.2019.04.017_bib14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jiac.2019.04.017_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2010.10.013","article-title":"Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy","volume":"37","author":"Wong-Beringer","year":"2011","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19301217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19301217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:59:06Z","timestamp":1761159546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19301217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1341321X19301217"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.04.017","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation for optimal dosing of vancomycin in patients with different physical types","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}